Volume 5, Issue 1, Pages (October 2013)

Slides:



Advertisements
Similar presentations
Volume 16, Pages (February 2017)
Advertisements

Volume 12, Issue 5, Pages (November 2007)
Volume 8, Issue 4, Pages (April 2017)
Genes with Bimodal Expression Are Robust Diagnostic Targets that Define Distinct Subtypes of Epithelial Ovarian Cancer with Different Overall Survival 
Volume 12, Issue 5, Pages (November 2007)
A Long Noncoding RNA Signature That Predicts Pathological Complete Remission Rate Sensitively in Neoadjuvant Treatment of Breast Cancer  Gen Wang, Xiaosong.
Christos Sotiriou, Chand Khanna, Amir A
Volume 2, Issue 4, Pages (April 2008)
Volume 10, Issue 6, Pages (December 2006)
Volume 21, Issue 3, Pages (October 2017)
Volume 14, Issue 12, Pages (March 2016)
Volume 5, Issue 4, Pages e5 (October 2017)
Volume 9, Issue 3, Pages (September 2017)
Volume 23, Issue 11, Pages (June 2018)
Volume 17, Issue 1, Pages (January 2010)
Volume 23, Issue 4, Pages (April 2018)
Volume 31, Issue 2, Pages (February 2017)
Volume 4, Issue 1, Pages (July 2013)
Understanding Tissue-Specific Gene Regulation
The Translational Landscape of the Mammalian Cell Cycle
Keiran S.M. Smalley  Journal of Investigative Dermatology 
Volume 11, Issue 5, Pages (May 2015)
Volume 4, Issue 3, Pages (August 2013)
Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound  Chun-Han Lin, Tiina Jokela,
Volume 25, Issue 5, Pages e5 (October 2018)
Human-Specific Transcriptional Networks in the Brain
Volume 19, Issue 10, Pages (June 2017)
Volume 58, Issue 4, Pages (May 2015)
Volume 22, Issue 3, Pages (January 2018)
Volume 24, Issue 4, Pages (July 2018)
Volume 8, Issue 4, Pages (April 2017)
Volume 22, Issue 8, Pages (August 2015)
Volume 17, Issue 8, Pages (November 2016)
Volume 22, Issue 13, Pages (March 2018)
Volume 24, Issue 12, Pages e5 (September 2018)
Volume 24, Issue 8, Pages (August 2018)
The Prognostic Ease and Difficulty of Invasive Breast Carcinoma
Volume 155, Issue 4, Pages (November 2013)
Volume 17, Issue 4, Pages (October 2016)
Volume 22, Issue 3, Pages (January 2018)
Volume 5, Issue 4, Pages e4 (October 2017)
Volume 23, Issue 3, Pages (March 2016)
Principles and Strategies for Developing Network Models in Cancer
Volume 37, Issue 6, Pages (December 2012)
Network Medicine Strikes a Blow against Breast Cancer
Volume 10, Issue 6, Pages (December 2006)
Volume 132, Issue 6, Pages (March 2008)
Volume 5, Issue 4, Pages e4 (October 2017)
Volume 10, Issue 6, Pages (December 2006)
Volume 4, Issue 3, Pages e3 (March 2017)
Volume 29, Issue 5, Pages (May 2016)
Subnetworks enriched for the hallmarks of cancer.
James M. Flanagan, Sibylle Cocciardi, Nic Waddell, Cameron N
Volume 15, Issue 12, Pages (June 2016)
Volume 26, Issue 12, Pages e5 (March 2019)
A Mathematical Model of the Liver Circadian Clock Linking Feeding and Fasting Cycles to Clock Function  Aurore Woller, Hélène Duez, Bart Staels, Marc.
Figure 1. Identification of three tumour molecular subtypes in CIT and TCGA cohorts. We used CIT multi-omics data ( Figure 1. Identification of.
Regulatory Genomic Data Cubism
Stephen Bridgett, James Campbell, Christopher J. Lord, Colm J. Ryan 
M-Wnt and E-Wnt cells cluster tightly with claudin-low and basal-like breast tumors, respectively, by microarray analysis. M-Wnt and E-Wnt cells cluster.
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
EN1-associated chromatin complexes in breast cancer cells.
Mutational Analysis of Ionizing Radiation Induced Neoplasms
Volume 26, Issue 11, Pages e6 (March 2019)
Volume 28, Issue 3, Pages e7 (July 2019)
Subtype classification of breast functional screening results.
Driver pathways and key genes in OSCC
Volume 28, Issue 4, Pages e6 (July 2019)
Fig. 3 Gene expression analysis in 48-plex drug treatment experiments.
Molecular Therapy - Nucleic Acids
Presentation transcript:

Volume 5, Issue 1, Pages 216-223 (October 2013) Signaling Network Assessment of Mutations and Copy Number Variations Predict Breast Cancer Subtype-Specific Drug Targets  Naif Zaman, Lei Li, Maria Luz Jaramillo, Zhanpeng Sun, Chabane Tibiche, Myriam Banville, Catherine Collins, Mark Trifiro, Miltiadis Paliouras, Andre Nantel, Maureen O’Connor-McCourt, Edwin Wang  Cell Reports  Volume 5, Issue 1, Pages 216-223 (October 2013) DOI: 10.1016/j.celrep.2013.08.028 Copyright © 2013 The Authors Terms and Conditions

Cell Reports 2013 5, 216-223DOI: (10.1016/j.celrep.2013.08.028) Copyright © 2013 The Authors Terms and Conditions

Figure 1 Analysis of Integrated Networks for Breast Cancer Cell Survival and Proliferation The data of genome sequencing, genome-wide RNAi screening, copy number variations, and gene expression profiles of individual lines were used for constructing an integrated network for each individual cell line. Cell-line-specific networks across each of the breast cancer subtypes were used for constructing subtype-specific networks for cancer cell survival and proliferation. Comparative and differential analysis of the subtype-specific networks allowed us to predict subtype-specific treatments and significantly classify breast tumor samples. See also Figure S1 and Table S1. Cell Reports 2013 5, 216-223DOI: (10.1016/j.celrep.2013.08.028) Copyright © 2013 The Authors Terms and Conditions

Figure 2 Hierarchical Clustering of the 16 Breast Cancer Cell Lines Hierarchical clustering of the cell lines using cell-line-specific network hubs: (A) driving-regulator hubs, (B) essential gene hubs, and (C) the hubs of essential genes and driving regulators combined. Red and beige in the heatmaps indicate whether the hub genes are present or absent, respectively, in a cell line. See also Table S3. Cell Reports 2013 5, 216-223DOI: (10.1016/j.celrep.2013.08.028) Copyright © 2013 The Authors Terms and Conditions

Figure 3 Subtype-Specific Survival Signaling Networks Subtype-specific survival signaling networks for basal A (A), basal B (B), and luminal (C) subtypes. Nodes represent genes while links represent regulation (directed links) or interaction (neutral links) between genes. A node is represented by a pie chart that shows each gene’s distribution as essential gene (red), a driving-regulator (blue), or a proliferation-influencing gene (cream) in its subtype. The background color behind the clusters represents a cluster’s function in relation to one of the cancer hallmarks: apoptosis (pink), cell proliferation (green), and cell cycle (blue). Cytoscape (Saito et al., 2012) was used to present and visualize the networks. See also Figure S2 and Table S4. Cell Reports 2013 5, 216-223DOI: (10.1016/j.celrep.2013.08.028) Copyright © 2013 The Authors Terms and Conditions

Figure 4 Clustering of 16 Breast Cancer Cell Lines and 402 Breast Tumor Samples Using the Hubs from Subtype-Specific Networks (A) Hierarchical clustering of the 16 cell lines using the differential hubs from the subtype-specific networks of luminal and basal subtypes. In the heatmap, for a given cell line, a hub gene appears in red if it is an essential gene, a driving regulator, or a proliferation-influencing gene; otherwise, it appears in beige. On the side bar, gray and yellow represent luminal and basal cell lines, respectively. (B) The same differential hubs from (A) were used to classify 402 breast tumor samples. In the heatmap, red represents mutated genes or amplified genes that are among the top 50% of the expressed genes for tumor samples. Cell Reports 2013 5, 216-223DOI: (10.1016/j.celrep.2013.08.028) Copyright © 2013 The Authors Terms and Conditions

Figure S1 Data Sources and Cutoff Values for Defining Driving Regulators and Essential and Proliferating-Influencing Genes, Related to Figure 1 For a given cell line, if a gene is among Top 75% of the expressed genes and its RNAi-screening p value < 0.05, it is defined as an essential gene in that cell line; if a gene is among Top 75% of the expressed genes and its RNAi-screening 0.05 > p value < 0.1, it is defined as a proliferation influencing gene in that cell line; if a gene is driver-mutating gene, or has a GISTIC score > 0.3, plus among Top 50% of the expressed genes, and if its RNAi-screening p value < 0.4, it is defined as a driving-regulator for cell survival in that cell line. Cell Reports 2013 5, 216-223DOI: (10.1016/j.celrep.2013.08.028) Copyright © 2013 The Authors Terms and Conditions

Figure S2 Dartboard Showing Overlap of Essential Genes and Driving Regulators for Cell-Line-Specific Networks of the Subtypes, Related to Figure 3 Overlapping of essential genes for basal A (A), basal B (C) and luminal (E) and overlapping of driving-regulators for basal A (B), basal B (D) and luminal (F). The outer most circle colored with peach (basal A and basal B) or gray (luminal) represents the number of genes that do not overlap with any other cell line within their respective subtype, and are therefore unique to that cell line. Going toward the center, the bull’s eye contains the number of genes shared by all the cell line-specific networks in that subtype. Cell Reports 2013 5, 216-223DOI: (10.1016/j.celrep.2013.08.028) Copyright © 2013 The Authors Terms and Conditions